Bayer and UHN reach two million-dollar goal
Unique partnership with UHN providing funding for important lung disease research and raising awareness of rare diseases
In the Fall of 2016, Bayer Inc. and Toronto General & Western Hospital Foundation (TGWHF) launched the Lung Matching Campaign. As part of the program, Bayer Inc. (Bayer) pledged to match, dollar-for-dollar, all donations to the Lung Program at University Health Network (UHN), up to a total of $1 million.
The Campaign also aimed to raise awareness about lung diseases, including Pulmonary Hypertension (PH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). CTEPH is a rare condition whereby blood clots in the lungs can block the flow of blood to a specific part of the lung, and cause increased pressure in the arteries (blood vessels) of the lungs.
Since the program’s inception, TGWHF has raised $1 million in private donations, which has been matched in full by Bayer – bringing the total to $2 million for the Lung Program! Through the Campaign, UHN has been able to support patients such as Jane Burfield, who was diagnosed with CTEPH. Jane was treated at Toronto General Hospital, which is part of UHN. After her treatment, she also donated to the Lung Matching Campaign, having seen the positive effects of the program firsthand.
“You see life with new eyes when it’s almost been taken away from you. I can’t speak highly enough of the staff at UHN,” says Jane. “They inspired me to support the Lung Program, and through the Lung Matching Campaign my gift was doubled by Bayer, helping even more patients like me breathe easy again.”
Bayer’s involvement in the program is part of its commitment to Science for a Better Life.
“Bayer is happy to support this meaningful program to help fund lung disease research and raise awareness about lung diseases in Canada,” says Alok Kanti, president and CEO, Bayer Inc. “I want to personally thank all of the donors that have made this program a success.”